CLASS II ONGOING Device recall · Reported 12 Jun 2024 · FDA Enforcement Report

BD Sars-CoV-2 Reagents for BD MAX" Systems recalled

Becton Dickinson & is recalling BD Sars-CoV-2 Reagents for BD MAX" Systems, distributed nationwide in the US. The recall was initiated on 7 May 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog No. 445003-01; UDI-DI: (01) 60382904450030 (17) 240803 (10) 3291356 (20) 01 (30) 1, (01) 60382904450030 (17) 241119 (10) 3291358 (20) 01 (30) 1, (01) 60382904450030 (17) 241217 (10) 3326001 (20) 01 (30) 1; Lot No. 3291356 (Exp. 8/3/24), 3291358 (Exp. 11/19/24), 3326001 (Exp. 12/17/24).
Quantity recalled2,061 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2023-2024
FDA event ID
94599
Recalling firm
Becton Dickinson &, Sparks, MD
Classification
Class II
Status
Ongoing
Recall initiated
7 May 2024
FDA classified
5 Jun 2024
Reported
12 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

7 May 2024Recall initiated by company
5 Jun 2024Classified by FDA+29 days
12 Jun 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.

Where it was distributed

Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.

Nationwide CaliforniaColorado

Questions about this recall

Is BD Sars-CoV-2 Reagents for BD MAX" Systems recalled?

Yes. Becton Dickinson & recalled BD Sars-CoV-2 Reagents for BD MAX" Systems on 7 May 2024. The recall is Class II and its status is Ongoing. Recall number Z-2023-2024.

Why was it recalled?

Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.

Which lots are affected?

Catalog No. 445003-01; UDI-DI: (01) 60382904450030 (17) 240803 (10) 3291356 (20) 01 (30) 1, (01) 60382904450030 (17) 241119 (10) 3291358 (20) 01 (30) 1, (01) 60382904450030 (17) 241217 (10) 3326001 (20) 01 (30) 1; Lot No. 3291356 (Exp. 8/3/24), 3291358 (Exp. 11/19/24), 3326001 (Exp. 12/17/24).

Where was it sold?

Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Test Kits & Diagnostics recalls

All 2,656